Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1993;73:898-905

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomita, N.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomita, N.
Right arrow Articles by Ogihara, T.

Circulation Research, Vol 73, 898-905, Copyright © 1993 by American Heart Association


ARTICLES

Hypertensive rats produced by in vivo introduction of the human renin gene

N Tomita, J Higaki, Y Kaneda, H Yu, R Morishita, H Mikami and T Ogihara
Department of Geriatric Medicine, Osaka University Medical School, Japan.

We established an efficient and nontoxic in vivo gene transfer method mediated by the Sendai virus (hemagglutinating virus of Japan [HVJ]), liposomes, and nuclear protein. In this study, to produce a hypertensive model rat that is dependent on human renin, the human renin gene was introduced into adult rat liver by our efficient in vivo gene transfer method using HVJ and liposomes (HVJ-liposomes). The rats treated with HVJ-liposomes containing the human renin gene showed a significant elevation of blood pressure for 6 days compared with control rats, which received injections of HVJ-liposomes without the human renin gene. On day 5 after the transfer, human active renin as well as angiotensin II were found in the plasma of rats in which the human renin gene was introduced. Moreover, the blood pressure of these rats was significantly correlated with the plasma levels of human active renin and angiotensin II. To confirm that the elevated blood pressure was due to the expression of the human renin gene, we administered a newly developed specific human renin inhibitor, FK 906. The elevated blood pressure was normalized by the intravenous administration of this drug. These data indicate that this hypertensive rat was produced by the in vivo transfer of the human renin gene into rat liver and that the expressed human renin cleaved rat substrate (angiotensinogen). This hypertensive rat produced by in vivo gene transfer should be useful in further studies on hypertension.


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
N. TOMITA, R. MORISHITA, H. Y. LAN, K. YAMAMOTO, M. HASHIZUME, M. NOTAKE, K. TOYOSAWA, B. FUJITANI, W. MU, D. J. NIKOLIC-PATERSON, et al.
In Vivo Administration of a Nuclear Transcription Factor-{kappa}B Decoy Suppresses Experimental Crescentic Glomerulonephritis
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1244 - 1252.
[Abstract] [Full Text]


Home page
Rheumatology (Oxford)Home page
T. Tomita, H. Takano, N. Tomita, R. Morishita, M. Kaneko, K. Shi, K. Takahi, T. Nakase, Y. Kaneda, H. Yoshikawa, et al.
Transcription factor decoy for NF{kappa}B inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis
Rheumatology, July 1, 2000; 39(7): 749 - 757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. K. Raizada, M. J. Katovich, H. Wang, K. H. Berecek, and C. H. Gelband
Is antisense gene therapy a step in the right direction in the control of hypertension?
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H423 - H432.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Nakamura, A. Moriguchi, R. Morishita, K. Yamada, T. Nishii, N. Tomita, M. Ohishi, Y. Kaneda, J. Higaki, and T. Ogihara
Activation of the Brain Angiotensin System by In Vivo Human Angiotensin-Converting Enzyme Gene Transfer in Rats
Hypertension, August 1, 1999; 34(2): 302 - 308.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Tomita, N. Tomita, T. Yamada, L. Zhang, Y. Kaneda, R. Morishita, T. Ogihara, V. J. Dzau, and M. Horiuchi
Transcription Factor Decoy to Study the Molecular Mechanism of Negative Regulation of Renin Gene Expression in the Liver In Vivo
Circ. Res., May 14, 1999; 84(9): 1059 - 1066.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Sawa, K. Kadoba, K. Suzuki, H.-Z. Bai, Y. Kaneda, R. Shirakura, and H. Matsuda
EFFICIENT GENE TRANSFER METHOD INTO THE WHOLE HEART THROUGH THE CORONARY ARTERY WITH HEMAGGLUTINATING VIRUS OF JAPAN LIPOSOME
J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 512 - 519.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. Morishita, J. Higaki, N. Tomita, M. Aoki, A. Moriguchi, K. Tamura, K. Murakami, Y. Kaneda, and T. Ogihara
Role of Transcriptional cis-Elements, Angiotensinogen Gene–Activating Elements, of Angiotensinogen Gene in Blood Pressure Regulation
Hypertension, March 1, 1996; 27(3): 502 - 507.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. Sawa, K. Suzuki, H.-Z. Bai, R. Shirakura, R. Morishita, Y. Kaneda, and H. Matsuda
Efficiency of In Vivo Gene Transfection Into Transplanted Rat Heart by Coronary Infusion of HVJ Liposome
Circulation, November 1, 1995; 92(9): 479 - 482.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Tomita, R. Morishita, J. Higaki, M. Aoki, Y. Nakamura, H. Mikami, A. Fukamizu, K. Murakami, Y. Kaneda, and T. Ogihara
Transient Decrease in High Blood Pressure by In Vivo Transfer of Antisense Oligodeoxynucleotides Against Rat Angiotensinogen
Hypertension, July 1, 1995; 26(1): 131 - 136.
[Abstract] [Full Text]